Search

CRISPR Recovery? “Furor” Briefly Snips $500M From Companies' Values

CRISPR RECOVERY? “FUROR” BRIEFLY SNIPS $500M FROM COMPANIES' VALUES

Is the J.P. Morgan CRISPR rollercoaster ride over? As rain fell heavily in San Francisco Monday, the first day of the massive healthcare...

 
 
 
Pharmacy Revenues Decline, Thanks to Cheaper Medicines

PHARMACY REVENUES DECLINE, THANKS TO CHEAPER MEDICINES

We've been saying it for some time , and the numbers speak for themselves : spending on prescription drugs is heading in the right...

 
 
 
Alder Plans for FDA Filing After Migraine Drug Posts Strong Results

ALDER PLANS FOR FDA FILING AFTER MIGRAINE DRUG POSTS STRONG RESULTS

Alder Therapeutics' migraine-prevention drug hit its main goal in a late-stage study, and the drug developer these early results keep...

 
 
 

SANGAMO THERAPEUTICS OUTLINES 2018 KEY PRIORITIES AND CATALYSTS AT J.P. MORGAN HEALTHCARE CONFERENCE

RICHMOND, Calif., Jan. 8, 2018 /PRNewswire/ - In meetings with investors this week and during a presentation Wednesday at the J.P....

Ultrasound Tracks Therapeutic Microbes Deep Inside the Body

ULTRASOUND TRACKS THERAPEUTIC MICROBES DEEP INSIDE THE BODY

Sound-based imaging reveals the location of engineered bacteria inside the gut or in tumors

 
 
 
 
 
 

UPSTART EXPANSION BAGS A $55M LAUNCH ROUND TO JOIN THE HUNT FOR RNA-TARGETING SMALL MOLECULES

Arrakis isn't the only biotech startup looking to develop RNA-targeted small molecule drugs. Now they have a rival in Expansion Therapeutics,...

KINDLER'S CENTREXION RAISES $67M TO FUND PHASE 3 PAIN TRIAL

Centrexion Therapeutics has raised $67 million. The Jeffrey Kindler-helmed biotech will use the cash to move nonopioid pain drug CNTX-4975...

 
 
 

PEAR THERAPEUTICS SCORES $50M IN SERIES B FUNDING ROUND

The financing will allow the company to commercialize its lead programs and further develop its pipeline and platform.

USING AN OLD MERCK DRUG, MENLO HOPES TO SCRATCH AN ITCH WITH $98M IPO

Six months after getting off a $50 million series C, late-stage California dermatology biotech Menlo Therapeutics is looking to take...

 
 
 

GIP(3 - 30)NH 2 IS AN EFFICACIOUS GIP RECEPTOR ANTAGONIST IN HUMANS: A RANDOMISED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, CROSSOVER STUDY

Abstract Aims/hypothesis Glucose-dependent insulinotropic polypeptide is an incretin hormone secreted postprandially from enteroendocrine...

ODONATE THERAPEUTICS ANNOUNCES INITIATION OF CONTESSA, A PHASE III STUDY OF TESETAXEL IN PATIENTS

In patients with MBC, tesetaxel was shown to have robust single-agent antitumor activity in two, multicenter, Phase 2 studies.

 
 
 

LOW-INTENSITY ULTRASOUND UPREGULATES THE EXPRESSION OF CYCLIN-D1 AND PROMOTES CELLULAR PROLIFERATION IN HUMAN MESENCHYMAL STEM CELLS

Human mesenchymal stem cells hold great potential for cellular based therapeutics and tissue engineering applications and their expansion...

68 GA-PSMA 11 LIGAND PET IMAGING IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY - DIAGNOSTIC PERFORMANCE AND IMPACT ON THERAPEUTIC DECISION-MAKING

Abstract Objective To evaluate the diagnostic performance of Ga-PSMA HBED-CC conjugate 11 positron emission tomography in the early...

 
 
 
New Computational Strategies Help Develop New Peptide Therapeutics

NEW COMPUTATIONAL STRATEGIES HELP DEVELOP NEW PEPTIDE THERAPEUTICS

New computational strategies can help develop new peptide-based drugs that are stable, potent and selective. Pharmacological properties...

Gene That Causes Inflammatory Bowel Disease Identified

GENE THAT CAUSES INFLAMMATORY BOWEL DISEASE IDENTIFIED

The gene MKL1 contributes to the development of colitis. Thus it may be a potential therapeutic target for the prevention of Inflammatory...